BIDMC scientists discover vulnerability that offers new strategy to combat triple-neg
 

Physicians currently have no targeted treatment options available for women diagnosed with an aggressive form of breast cancer known as triple-negative breast cancer, leaving standard-of-care chemotherapies as a first line of defense against the disease.

More...